2018
DOI: 10.3389/fendo.2018.00021
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome

Abstract: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder defined by ROME IV criteria as pain in the lower abdominal region, which is associated with altered bowel habit or defecation. The underlying mechanism of IBS is not completely understood. IBS seems to be a product of interactions between various factors with genetics, dietary/intestinal microbiota, low-grade inflammation, and stress playing a key role in the pathogenesis of this disease. The crosstalk between the immune system and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 42 publications
(37 citation statements)
references
References 73 publications
0
34
0
1
Order By: Relevance
“…The CRF system also influences some functions within the gastrointestinal system, including gut motility and permeability [67]. Interestingly, animal studies showed that increased CRF might be associated with alteration in the intestinal microbial community (i.e., reduction in Lactobacillus), as well, an opposite relation has been found between alteration of the CRF signaling (i.e., CRF-mediated activation of the HPA axis) and changes in the gut microbiota [68].…”
Section: Gut-brain Axismentioning
confidence: 99%
“…The CRF system also influences some functions within the gastrointestinal system, including gut motility and permeability [67]. Interestingly, animal studies showed that increased CRF might be associated with alteration in the intestinal microbial community (i.e., reduction in Lactobacillus), as well, an opposite relation has been found between alteration of the CRF signaling (i.e., CRF-mediated activation of the HPA axis) and changes in the gut microbiota [68].…”
Section: Gut-brain Axismentioning
confidence: 99%
“…These neuroendocrine peptides are best known for their involvement in regulating the physiological and behavioural responses to stress, through the cognate G-protein-coupled receptors (GPCRs), CRH receptor 1 (CRHR1) and CRH receptor 2 (CRHR2) (Chen et al 1993, Lovenberg et al 1995, Weninger et al 1999, Bakshi et al 2002, as part of the hypothalamic-pituitary-adrenal (HPA) axis. More recent evidence suggests additional, diverse, extra-hypothalamic roles for these peptides in peripheral organs (Paschos et al 2013, Chatoo et al 2018, Chatzaki et al 2019. Thus, CRH expression has been reported in the adrenal gland and the gastrointestinal tract (Suda et al 1984); UCN1 is expressed in heart, skin and adipose tissue (Kimura et al 2002, Seres et al 2004, Wierzbicka et al 2017; and UCN2 and UCN3 have been detected in peripheral blood cells, skeletal muscle, pancreas and gestational tissues such as foetal membranes and placental villi (Petraglia et al 2010).…”
Section: Introductionmentioning
confidence: 99%
“…The CRF system also modulates visceral hypersensitivity [26] and gut motility in animal models of stress [27]. It is also implicated in the modulation of gut motility and mood behavior in IBS patients [28]. We previously documented increased levels of CRFRs in duodenal biopsies of patients with Crohn’s disease [15], but the status of CRFRs in IBS patients is unknown.…”
Section: Introductionmentioning
confidence: 99%